Skip to NavigationSkip to content


Shares in UK vaccines specialist PowderJect rose nearly 8% after it confirmed an unnamed company had made a buyout offer.
GlaxoSmithKline has posted 11% growth in the first quarter of 2003 despite generic competition for its blockbuster antibiotic Augmentin.
OTC omeprazole to become Glaxo's next generation Zantac
Sanofi-Synthelabo has upgraded its full-year share earnings guidance for 2003, despite its plans to spend more on R&D.
Doctors and health unions have expressed their concerns about the effect of new fast track surgery centres on the rest of the NHS.
GlaxoSmithKline has cut prices of its HIV/AIDS drugs for developing countries by nearly half following intense pressure from campaigners and...
International sales of several key drugs helped Bristol-Myers Squibb to minimise the effects of continued US generic competition in the first quarter...
Nearly three in five doctors would like to be able to charge their patients for home visits, according to a new survey.
The Government is to modify one of its key waiting times targets after sustained protests about its inability to reflect the needs of all patients.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches